ArticlePloS one2025
Unraveling multimodality of digital health records by comparing mortality trajectories of diagnoses of diseases from over 12 million patients.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluation of trajectory analysis for disease risk assessment: a scoping review.Journal of the American Medical Informatics Association : JAMIA · 2026Article
Corrections and comments
- Update of
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Understanding the multimodality of digital health data, including the scope of death records, is essential for adequate data acquisition to build a research framework for the health sciences. In this study, I leveraged the diverse healthcare records of over 12 million patients to reconstitute mortality trajectories that navigate the sequence of disease processes shared among patients from initial presentation through interim conditions that ultimately terminate in fatal outcomes. I conducted a comprehensive analysis of longitudinal discharge records for 10.4 million patients from US hospitals, utilizing the US State Inpatient Data (USSID) including 290,253 records of deaths in clinics. I also scrutinized the cross-sectional records of Korea from the billing reviews, specifically the National Inpatients Set of Korea (NISK), encompassing 2.1 million patients. By tracing the diagnostic timelines of patients diagnosed with significant comorbid diseases (False Discovery Rate (FDR) <0.1), I built mortality trajectories, mapping the temporal progression of disease diagnoses resulting in death. My trajectory model rewired 705 significant mortality trajectories across both datasets (USSID and NISK). The presented mortality trajectories successfully recapitulated established patterns of mortality for each country, while also revealing different trajectories leading to death, influenced by the modality of data. For example, viral hepatitis, a known predisposing feature of liver cancer in Asia, was observed to initiate in younger Koreans. Interestingly, owing to the collection of hospital records, the modeled mortality trajectories derived from the USSID converged towards sepsis. Although a substantial sequence of diagnostic processes is shared between USSID and NISK, the multimodality of these two datasets highlights different diagnoses preceded by fatal outcomes. Unraveling mortality patterns is feasible with an appropriate understanding of the multimodality of digital health data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.